发明公开
EP1711191A2 CHLORITE IN THE TREATMENT OF NEURODEGENERATIVE DISEASE
有权
CHLORIT BEI DER BEHANDLUNG AMYOTROPHER LATERALSKLEROSE
- 专利标题： CHLORITE IN THE TREATMENT OF NEURODEGENERATIVE DISEASE
- 专利标题（中）： CHLORIT BEI DER BEHANDLUNG AMYOTROPHER LATERALSKLEROSE
-
申请号： EP05722556.7申请日： 2005-01-25
-
公开(公告)号： EP1711191A2公开(公告)日： 2006-10-18
- 发明人: MCGRATH, Michael S.
- 申请人： The Regents of the University of California, Office of the President
- 申请人地址： 1111 Franklin Street 12th Floor Oakland, CA 94602-5200 US
- 专利权人： The Regents of the University of California, Office of the President
- 当前专利权人： The Regents of the University of California, Office of the President
- 当前专利权人地址： 1111 Franklin Street 12th Floor Oakland, CA 94602-5200 US
- 代理机构： Williams, Richard Andrew Norman
- 优先权： US541576P 20040203
- 国际公布： WO2005076819 20050825
- 主分类号： A61K33/00
- IPC分类号： A61K33/00
摘要：
The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.
公开/授权文献
- EP1711191B1 CHLORITE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS 公开/授权日：2014-03-19
信息查询
